Filter
868
Text search:
Antigen
testing
Featured
Recommendations
127
New Publications
227
Language
Document type
No document type
447
Guidelines
198
Studies & Reports
91
Manuals
46
Fact sheets
34
Strategic & Response Plan
30
Training Material
9
Resource Platforms
4
Situation Updates
3
Online Courses
3
Infographics
2
Videos
1
Countries / Regions
India
55
Global
30
South Africa
23
Nigeria
20
Kenya
19
Africa
19
Western and Central Europe
17
Tanzania
16
Zambia
14
East and Southern Africa
14
Sierra Leone
13
Philippines
13
Uganda
12
Germany
12
West and Central Africa
12
Nepal
11
Rwanda
11
Ukraine
11
Liberia
10
Malawi
10
Russia
10
Ghana
9
Latin America and the Carribbean
9
Ethiopia
8
Zimbabwe
8
Namibia
8
Middle East and North Africa
7
Myanmar / Burma
6
Eastern Europe and Central Asia
6
Congo, Democratic Republic of
5
Syria
5
Bangladesh
5
USA
4
Cambodia
4
Mozambique
4
Brazil
4
Eastern Europe
4
Saudi Arabia
3
Cameroon
3
Indonesia
3
Lesotho
3
South–East Asia Region
3
Albania
3
Burkina Faso
2
Somalia
2
Pakistan
2
Iraq
2
Jordan
2
Lebanon
2
Sudan
2
Eswatini/ Swaziland
2
Colombia
2
Libya
2
Asia
2
Iran
2
Guinea
1
Mali
1
Morocco
1
Haiti
1
South Sudan
1
Afghanistan
1
Egypt
1
China
1
Central African Republic
1
Peru
1
North Macedonia
1
Ecuador
1
Botswana
1
Greece
1
Angola
1
Madagascar
1
Chile
1
Yemen
1
Palestine
1
Djibouti
1
Qatar
1
Moldova
1
Kazakhstan
1
Georgia
1
North America
1
Tunisia
1
United Kingdom
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
323
Clinical Guidelines
130
Pharmacy & Technologies
42
Public Health
26
Women & Child Health
18
Key Resources
17
Capacity Building
7
Toolboxes
COVID-19
170
HIV
123
TB
58
Rapid Response
55
NTDs
45
Ebola
36
Refugee
15
Pharmacy
15
Zika
12
AMR
11
Conflict
10
Caregiver
10
Cholera
7
Mental Health
6
Polio
4
Planetary Health
4
Natural Hazards
3
NCDs
3
Global Health Education
2
Health Financing Toolbox
2
WHO estimates that in 2015, 257 million people were living with chronic hepatitis B virus (HBV) infection worldwide, and that 900 000 died from HBV infection, mostly through the development of cirrhosis and hepatocellular carcinoma. Worldwide, the majority of persons with chronic hepatitis B infecti
...
This document aims to provide guidance to healthcare facilities and healthcare providers in the European Union/European Economic Area (EU/EEA) and the United Kingdom (UK) on preparedness and infection prevention and control (IPC) measures for the management of possible and confirmed cases of COVID-1
...
The Zambia Population Based HIV impact assessment of 2016, reported the prevalence of viral hepatitis in Zambia as ranging between 5.6% among adults aged 15 to 59% in the general population, and 7.1% among HIV infected individuals. It is estimated that the majority of persons with chronic hepatitis
...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV‑2) causing coronavirus disease 2019 (COVID-19) has reached pandemic levels;
Patients with cardiovascular (CV) risk factors and established cardiovascular disease (CVD) represent a vulnerable population when suffering from COVID-19;
Patien
...
Will COVID-19 vaccines be safe? Will all the COVID-19 candidate vaccines be successful? What are the different phases a vaccine must go through to be approved? This document provides responses to the most frequently asked questions about candidate vaccines and access to COVID-19 vaccination.
В этом документе представлены временные рекомендации для лабораторий и других заинтересованных сторон,
принимающих участие в диагностической работе для выявлен
...
The guide explains how vaccines work and answers your common questions as well as providing up-to-date information on the current approved COVID-19 vaccinations in the UK.
This guide was written in January 2021 and updated in March 2021 and is accurate at the time of publishing. Information will b
...
Five years after a global commitment to Fast-Track the HIV response and end AIDS by 2030, the world is off track. A promise to build on the momentum created in the first decade of the twenty-first century by front-loading investment and accelerating HIV service provision has been fulfilled by too fe
...
Slideset updated regularly to include the latest data and guidance on COVID-19 risk and management in special populations, including children and pregnant women, and persons with comorbidities.
26 March 2021 Slideset updated regularly to include the latest data on the evolution and duration of COVID-19 symptoms and prevalence and duration of natural immunity.
Nat Med (2021). https://doi.org/10.1038/s41591-021-01381-y
In 2020, the COVID-19 pandemic impacted the world beyond imagination. To date, it has infected more than 135 million people, killed over 2.9 million people, and is projected to plunge up to 115 million people into extreme poverty.1 As countries have gone into lockdown, gender-based violence has incr
...
21 January 2022
The overall threat posed by Omicron largely depends on four key questions: (i) how transmissible the variant is; (ii) how well vaccines and prior infection protect against infection, transmission, clinical disease and death; (iii) how virulent the variant is compared to other varian
...
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
